fbpx
Medical Innovation Exchange

Biogen CEO Michel Vounatsos points to inherent risk in neuroscience as 3 programs cut

https://www.fiercebiotech.com/biotech/biogen-ceo-michel-vounatsos-points-inherent-risk-neuroscience-3-programs-cut

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.